๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-strep)

โœ Scribed by N. Kemeny; A. Yagoda; D. Braun Jr; R. Golbey

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
535 KB
Volume
45
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Metastatic colorectal carcinoma: A prosp
Metastatic colorectal carcinoma: A prospective randomized trial of Methyl-CCNU, 5-fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-strep)
โœ Nancy Kemeny; Alan Yagoda; David Braun Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

A Prospective Randomized Trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and Vincristine (MOF) Versus MOF Plus Streptozotocin (MOF-Strep) A prospective randomized trial evaluated semustine (Methyl CCNU) 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep) in 75 patients

Combination chemotherapy of colorectal c
Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine
โœ Joss, Rudolf A. ;Goldberg, Ronald S. ;Yates, Jerome W. ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 280 KB

The combination of 5-fluorouracil (5-FU), methyl-1,3-cis(2-chlorethyl)-1-nitrosourea (methylCCNU), and vincristine (VCR) has been reported to produce a 43.5% response rate in metastatic colorectal cancer, although subsequent studies did not produce such good response rates. The clinical trial report